Home
Home

Anika

This Week in Biotech

This Week in Biotech
Motley Fool

Anika Therapeutics: Growth Stock At Value Prices With Near-Term FDA Catalyst

Anika Therapeutics: Growth Stock At Value Prices With Near-Term FDA Catalyst
Seeking Alpha

3 High-Growth Biotech Stocks With Encouraging Inventory Trends

3 High-Growth Biotech Stocks With Encouraging Inventory Trends
Seeking Alpha

4 Undervalued Healthcare Stocks With Strong Inventory Trends

4 Undervalued Healthcare Stocks With Strong Inventory Trends
Seeking Alpha

3 Liquid Biotech Stocks With Impressive Growth Projections

3 Liquid Biotech Stocks With Impressive Growth Projections
Seeking Alpha

Anika Therapeutics: A Bio-Pharma Poised For Long Term Gains

Anika Therapeutics: A Bio-Pharma Poised For Long Term Gains
Seeking Alpha

3 Hot Pharmas With Skin In The Game

3 Hot Pharmas With Skin In The Game
Seeking Alpha

5 Biotech Stocks Undervalued By EPS Trends

5 Biotech Stocks Undervalued By EPS Trends
Seeking Alpha

Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Submitted by moderatora on Tue, 04/26/2011 - 23:20

Device News

Genzyme Sues to Block Zimmer, Anika Treatments for Knee Pain
Bloomberg